m;C) may cause the canister to burst.
•
Do not throw the BEVESPI AEROSPHERE canister into a fire or an incinerator.
•
Throw away BEVESPI AEROSPHERE 3 months after you open the foil pouch or when the dose indicator reaches zero “0”, whichever comes first.
•
Keep BEVESPI AEROSPHERE and all medicines out of the reach of children.
General Information about the safe and effective use of BEVESPI AEROSPHERE
Medicines are sometimes prescribed for purposes other than those listed in a Medication Guide. Do not use BEVESPI AEROSPHERE for a condition for which it was not prescribed. Do not give your BEVESPI AEROSPHERE to other people, even if they have the same condition that you have. It may harm them.
This Medication Guide summarizes the most important information about BEVESPI AEROSPHERE. If you would like more information, talk with your healthcare provider or pharmacist. You can ask your healthcare provider or pharmacist for information about BEVESPI AEROSPHERE that was written for healthcare professionals.
For more information, call 1-800-236-9933 or go to www.BEVESPI.com.
What are the ingredients in BEVESPI AEROSPHERE?
Active ingredients: micronized glycopyrrolate and micronized formoterol fumarate
Inactive ingredients: hydrofluoroalkane (HFA 134a) and porous particles (comprised of DSPC [1,2-Distearoyl-sn-glycero-3-phosphocholine] and calcium chloride)
Manufactured for: AstraZeneca Pharmaceuticals LP, Wilmington, DE 19850; Manufactured by: Aventis Pharma LTD, Holmes Chapel CW48BE, United Kingdom
©AstraZeneca 2016
This Medication Guide has been approved by the U.S. Food and Drug Administration
April 2016
INSTRUCTIONS FOR USE
BEVESPI AEROSPHERE™
(be-VES-pee AIR-oh-sfeer)
(glycopyrrolate and formoterol fumarate)
Inhalation aerosol, for oral inhalation use
Read this Instructions for Use before you start using BEVESPI AEROSPHERE and each time you get a refill. There may be new information. This information does not take the place of talking to your healthcare provider about your medical condition or treatment.
Important Information:
•
For oral inhalation use only.
•
Use BEVESPI AEROSPHERE exactly as your healthcare provider tells you to.
•
If you have any questions about the use of your inhaler, ask your healthcare provider or pharmacist.
Parts of your BEVESPI AEROSPHERE inhaler (See Figure 1):
•
BEVESPI AEROSPHERE comes as a canister that fits into an actuator with a dose indicator.
° Do not use the BEVESPI AEROSPHERE actuator with a canister of medicine from any other inhaler.
° Do not use the BEVESPI AEROSPHERE canister with an actuator from any other inhaler.
Figure 1
•
BEVESPI AEROSPHERE comes with a dose indicator located on the top of the canister (See Figure 1). The dose indicator display window will show you how many puffs of medicine you have left. A puff of medicine is released each time you press the center of the dose indicator.
Before you use BEVESPI AEROSPHERE for the first time make sure that the pointer on the dose indicator is pointing to the right of the “120” inhalation mark in the dose indicator display window (See Figure 1). (Note, the pointer will point to the right of the “30” inhalation mark if you have a 7-day inhaler.)
•
The pointer will be pointing to 120 after 10 puffs are delivered from BEVESPI AE |
